TRAW — Traws Pharma, Inc.

TRAWTraws Pharma, Inc.

NAS · US · Healthcare · Biotechnology · trawspharma.com

1.585USD+6.38%Mkt Cap: 23.79M USDP/E: —Last update: 2026-05-26

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and CO…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap23.79M USD

Enterprise Value19.44M USD

Revenue (TTM)2.73M USD

Gross Profit2.73M USD

Net Income (TTM)9.17M USD

Revenue/Share0.2990 USD

Last Price1.585 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees4

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.37

PEG—

EV/EBITDA-1.00

EV/Revenue7.11

P/S8.26

P/B-21.59

EPS (TTM)-1.87

EPS (Forward)-4.03

52W Range

1.00026% of range3.270

52W High3.270 USD

52W Low1.000 USD

Profitability

Gross Margin100.00%

Oper. Margin-717.82%

EBITDA Margin0.00%

Profit Margin328.67%

ROE-1457.87%

ROA86.37%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.18M USD

CapEx (TTM)2.58M USD

FCF Margin-395.91%

FCF Yield-45.49%

Net Debt-3.13M USD

Net Debt/EBITDA0.16

Balance Sheet

Debt/Equity—

Current Ratio0.43

Quick Ratio0.36

Book Value/Sh-0.0690 USD

Cash/Share0.2070 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateSep 23, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)5.500 USD

Target Range3.000 USD – 8.000 USD

# Analysts2

Ownership

Shares Out.15.15M

Float8.00M

Insiders10.46%

Institutions29.79%

Short Interest

Short Ratio2.3d

Short % Float4.50%

Short % Out.3.70%

Shares Short560.04K

Short (prev mo.)411.64K

Technical

SMA 501.667 (-4.9%)

SMA 2001.888 (-16.0%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)4.41M

Avg Vol (10d)12.54M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—